CREDIBLE SCIENCE CREDIBLE TECHNOLOGY CREDIBLE RESULTS Trademark

Trademark Overview

On Thursday, April 27, 2017, a trademark application was filed for CREDIBLE SCIENCE CREDIBLE TECHNOLOGY CREDIBLE RESULTS with the United States Patent and Trademark Office. The USPTO has given the CREDIBLE SCIENCE CREDIBLE TECHNOLOGY CREDIBLE RESULTS trademark a serial number of 87428320. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 17, 2021. This trademark is owned by Ananda Scientific, Inc.. The CREDIBLE SCIENCE CREDIBLE TECHNOLOGY CREDIBLE RESULTS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely, pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets for weight control, appetite suppression, muscle relaxation, sleep disorders; nutritional supplements
credible science credible technology credible results

General Information

Serial Number87428320
Word MarkCREDIBLE SCIENCE CREDIBLE TECHNOLOGY CREDIBLE RESULTS
Filing DateThursday, April 27, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 17, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"TECHNOLOGY" AND "SCIENCE"
Goods and Servicespharmaceuticals, for the regulation of body systems, namely, for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely, pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets for weight control, appetite suppression, muscle relaxation, sleep disorders; nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnanda Scientific, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDraper, UT 84020

Trademark Events

Event DateEvent Description
Tuesday, May 18, 2021EXPARTE APPEAL TERMINATED
Tuesday, May 18, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 17, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 17, 2021ASSIGNED TO EXAMINER
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Monday, August 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 10, 2020NON-FINAL ACTION E-MAILED
Monday, February 10, 2020NON-FINAL ACTION WRITTEN
Monday, February 10, 2020EXAMINER'S AMENDMENT ENTERED
Monday, February 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2020EXAMINERS AMENDMENT E-MAILED
Monday, February 10, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION WRITTEN
Thursday, June 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 5, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 5, 2018NON-FINAL ACTION WRITTEN
Tuesday, November 20, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, November 15, 2018EXAMINERS REQUEST FOR REMAND TO TTAB
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Monday, September 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 6, 2018ASSIGNED TO LIE
Thursday, August 23, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 23, 2018EX PARTE APPEAL-INSTITUTED
Thursday, August 23, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, August 23, 2018EXPARTE APPEAL RECEIVED AT TTAB
Friday, June 1, 2018ASSIGNED TO EXAMINER
Friday, February 23, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 23, 2018FINAL REFUSAL E-MAILED
Friday, February 23, 2018FINAL REFUSAL WRITTEN
Thursday, February 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 31, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 31, 2017NON-FINAL ACTION E-MAILED
Monday, July 31, 2017NON-FINAL ACTION WRITTEN
Monday, July 24, 2017ASSIGNED TO EXAMINER
Wednesday, May 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 1, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

credible results science technology disorders muscular sleep disease pharmaceuticals diseases namely agents therapeutics health